-
Product Insights
Innovation in construction: floating breakwaters
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the construction industry’s floating breakwaters segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based on...
-
Thematic Analysis
NewHigh-Performance Computing – Thematic Intelligence
Supercomputers have existed since the 1960s, but there has been renewed interest in high-performing machines in the last decade following developments in artificial intelligence (AI) and the exponential growth in data. Businesses, governments, and individuals generate huge volumes of data every day, and organizations use high-performance computing (HPC) to store, process, and analyze large, complex workloads to extract value from this data. In the last decade, the commercial use cases for HPC have expanded, supported by improvements in AI, cloud,...
-
Product Insights
NewComputed Tomography (CT) Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Computed Tomography (CT) is a powerful, non-destructive evaluation technique used for producing 2D and 3D cross-sectional image of an object from a flat X-ray image. Computed Tomography (CT) is used on patients with a high risk of colon cancer, or full-motion heart scans for patients with high risk of heart disease. It can also be used for image complex fractures, detect infarction, tumors, calcifications, hemorrhage and bone trauma and also acute and chronic changes in the lung parenchyma etc. The...
-
Thematic Analysis
NewState of the Biopharmaceutical Industry 2024 Edition (Mid-Year Update) – Thematic Intelligence
Reasons to buy the ‘State of the Biopharmaceutical Industry 2024’ thematic intelligence report: Highlight the business environment and the industry, regulatory, and macroeconomic trends that are going to shape the biopharmaceutical industry in the next 12 months. Benchmark the impact of major themes on the biopharmaceutical industry in the next 12 months, Identify themes that will have the greatest positive or negative impact in the coming months. Comprehend the opinions of industry respondents on these themes. Predict the industry’s growth prospects...
-
Company Insights
NewAlipay – Competitor Profile
Launched in 2004, Alipay is among the leading alternative payment services providers (PSP) globally. It is a subsidiary of Ant Group, which is controlled by Alibaba Group. Alipay allows users to make fund transfers as well as online, in-app, and in-store payments at home and abroad. It is the primary method of payment for Alibaba’s online marketplaces, including AliExpress, Tmall, and Taobao. Alipay is accepted in more than 110 countries, allowing Chinese tourists to make payments in Chinese renminbi and...
-
Thematic Analysis
NewCybersecurity in Sport – Thematic Intelligence
No company is safe from cyberattacks, but sports organizations are more vulnerable than most. The business of sport naturally accrues a large amount of sensitive data, from fans’ personal data to performance data on athletes. The UK National Cyber Security Centre survey found that more than 70% of sports organizations had experienced a cybersecurity breach, more than double the UK average. Sports teams, federations, broadcasters, and sponsors are all vulnerable to attacks due to their significant revenues, the exposure any...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ustekinumab Biosimilar in Plaque Psoriasis (Psoriasis Vulgaris)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ustekinumab Biosimilar in Plaque Psoriasis (Psoriasis Vulgaris) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ustekinumab Biosimilar in Plaque Psoriasis (Psoriasis Vulgaris) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sym-023 in Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sym-023 in Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sym-023 in Lymphoma Drug Details: Sym-023 is under development for the treatment...
-
Product Insights
NewHearing Aid Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Hearing Aid Devices Pipeline Market Report Overview Hearing aid devices are the electronic device that amplifies and transmits sound, used by people with impaired hearing. The hearing aid devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pembrolizumab Biosimilar in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pembrolizumab Biosimilar in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pembrolizumab Biosimilar in Non-Small Cell Lung Cancer Drug...